| Stereoselectivity in the cytochrome P450-dependent N-demethylation and flavin monooxygenase-dependent N-oxidation of N,N-dimethylamphetamine. | 2014-02-12 |
| CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina. | 2014-02-12 |
| Identification of cytochrome P450s involved in the metabolism of arachidonic acid in human platelets. | 2014-02-12 |
| Impact of the CYP2C19*17 polymorphism on the clinical outcome of clopidogrel therapy in Asian patients undergoing percutaneous coronary intervention. | 2014-02-12 |
| Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population. | 2014-02-12 |
| Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine. | 2014-02-12 |
| Glucuronidation of a sarpogrelate active metabolite is mediated by UDP-glucuronosyltransferases 1A4, 1A9, and 2B4. | 2014-02-12 |
| A UGT1A1*28 and *6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer. | 2014-02-12 |
| Characterization of in vitro metabolites of luotonin A in human liver microsomes using electrospray/tandem mass spectrometry. | 2014-02-12 |
| Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patients. | 2014-02-12 |
| Different effects of clopidogrel and clarithromycin on the enantioselective pharmacokinetics of sibutramine and its active metabolites in healthy subjects. | 2014-02-12 |
| Identification and characterization of novel alternative splice variants of human constitutive androstane receptor in liver samples of Koreans and Caucasians. | 2014-02-12 |
| Effect of HNF4α genetic polymorphism G60D on the pharmacokinetics of CYP2D6 substrate tolterodine in healthy Korean individuals. | 2014-02-12 |
| Effects of clopidogrel and clarithromycin on the disposition of sibutramine and its active metabolites M1 and M2 in relation to CYP2B6*6 polymorphism. | 2014-02-12 |
| Effects of clopidogrel and itraconazole on the disposition of efavirenz and its hydroxyl metabolites: exploration of a novel CYP2B6 phenotyping index. | 2014-02-12 |
| LC-MS/MS for the simultaneous analysis of arachidonic acid and 32 related metabolites in human plasma: Basal plasma concentrations and aspirin-induced changes of eicosanoids. | 2014-02-12 |
| Pharmacokinetic effect of voriconazole on cyclosporine in the treatment of aspergillosis after renal transplantation. | 2014-02-12 |
| Comparison of CYP3A4 and CYP3A5: the effects of cytochrome b5 and NADPH-cytochrome P450 reductase on testosterone hydroxylation activities. | 2014-02-12 |
| Effects of testosterone and 17β-oestradiol on expression of the G protein-coupled receptor P2Y12 in megakaryocytic DAMI cells. | 2014-02-12 |
| Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition. | 2014-02-12 |
| Inter-individual variability in OCT1 expression and its relationship with OCT1 genotype in liver samples from a Korean population. | 2014-02-12 |
| Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer. | 2014-02-12 |
| Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5. | 2014-02-12 |
| Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. | 2014-02-12 |
| The disposition of three phosphodiesterase type 5 inhibitors, vardenafil, sildenafil, and udenafil, is differently influenced by the CYP3A5 genotype. | 2014-02-12 |
| Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry. | 2014-02-12 |
| Association between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients with Tamoxifen Treatment. | 2014-02-12 |
| Enantioselective carbonyl reduction of eperisone in human liver microsomes. | 2014-02-12 |
| In vitro metabolism and transport of the new dipeptidyl peptidase 4 inhibitors, KR66222 and KR66223. | 2014-02-12 |
| Genetic polymorphisms in Na(+)-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations. | 2014-02-12 |